Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
1.590
-0.010 (-0.63%)
At close: Sep 26, 2025, 4:00 PM EDT
1.562
-0.028 (-1.77%)
After-hours: Sep 26, 2025, 7:39 PM EDT
Mustang Bio Market Cap
Mustang Bio has a market cap or net worth of $11.51 million as of September 26, 2025. Its market cap has increased by 16.26% in one year.
Market Cap
11.51M
Enterprise Value
-1.15M
1-Year Change
16.26%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since August 22, 2017, Mustang Bio's market cap has decreased from $257.00M to $11.51M, a decrease of -95.52%. That is a compound annual growth rate of -31.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 11.50M | 35.29% |
| Dec 31, 2024 | 8.50M | -31.45% |
| Dec 29, 2023 | 12.40M | -70.75% |
| Dec 30, 2022 | 42.40M | -72.66% |
| Dec 31, 2021 | 155.10M | -37.18% |
| Dec 31, 2020 | 246.90M | 49.18% |
| Dec 31, 2019 | 165.50M | 106.36% |
| Dec 31, 2018 | 80.20M | -74.50% |
| Dec 29, 2017 | 314.50M | 22.37% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 641.51B |
| Johnson & Johnson | 428.03B |
| AbbVie | 386.06B |
| UnitedHealth Group | 312.96B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 226.78B |